ACCESSWIRE
10 May 2022, 06:25 GMT+10
Live Video Webcast Event with Russ Trenary, President and CEO of Outlook Therapeutics on Wednesday, May 11th at 1:00 PM ET
FRENCHTOWN, NJ / ACCESSWIRE / May 9, 2022 / JTC Team ('JTC'), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor CEO Spotlight Event Featuring Outlook Therapeutics on Wednesday, May 11, 2022 at 1:00 PM ET. Access the event here.
Outlook Therapeutics is a pre-commercial biopharmaceutical company working to develop and launch ONS-5010/ LYTENAVA™ (bevacizumab-vikg), an investigational therapy, as the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, including wet AMD, DME and BRVO. Outlook Therapeutics has submitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ONS-5010 to treat wet AMD. The submission is supported by Outlook Therapeutics' wet AMD registration clinical program, which consists of three clinical trials: NORSE ONE, NORSE TWO, and NORSE THREE. If ONS-5010 ophthalmic bevacizumab is approved, Outlook Therapeutics expects to commercialize it as the first and only FDA-approved ophthalmic formulation of bevacizumab for use in treating retinal diseases in the United States, United Kingdom, Europe, Japan and other markets.
A live video webcast of the Spotlight event will be available on www.virtualinvestorco.com. A webcast replay will be made available shortly after the conclusion of the live event and will be accessible for 90 days.
About JTC Team
JTC is a fully integrated corporate communications firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on Twitter and LinkedIn.
CONTACT:
Jenene Thomas
JTC Team, LLC
T: +1 (833) 475-8247
jtc@jtcir.com
SOURCE: JTC Team, LLC
Get a daily dose of Boston Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Boston Star.
More InformationSANTIAGO, Chile: Easter Island, one of Chile's most important tourist attractions, will reopen to visitors on August 1, the government ...
NEW DEHLI, India: In a move expected to end the country's exports of the raw materials needed to manufacture steel, ...
NEW YORK, New York - The release of the minutes of the Federal Reserve's monetary meeting earlier this month surprisingly ...
WASHINGTON D.C.: A leading U.S. official has said that even if Taiwan is excluded from President Joe Biden's Asian economic ...
MOSCOW, Russia: In the latest escalation of an energy payment dispute with Western nations, Russia's Gazprom has halted gas exports ...
SYDNEY, NSW, Australia - It was a lukewarm day for stocks across Asia Wednesday with little movement in either direction.In ...
Jake Burger launched a go-ahead, three-run home run in the fifth inning and Lucas Giolito pitched six innings of one-run ...
Jaylen Brown scored 25 points and Jayson Tatum added 22 points and 12 rebounds as the visiting Boston Celtics moved ...
It will be the Miami Heat's chance to turn the tables in the Eastern Conference finals when they play host ...
Veteran center Joe Thornton saw the Florida Panthers' season come to an abrupt end earlier this week. Thornton, however, wasn't ...
T1 announced the signing Wednesday of Sang-beom "Munchkin" Byeon to their evolving Valorant roster. The 24-year-old South Korean previously competed ...
Tuesday's 16-run barrage against the Chicago White Sox gave the Boston Red Sox 95 runs in their past 13 games. ...